Quintiles.com

  • Clinical Development Opportunities

    When can Quintiles help you?

    Many companies have a pipeline of multiple promising development candidates but are prevented from investing optimally in each one for a variety of reasons including budgetary or cash flow constraints. Our capital group aims to help you bring more products to market faster. Through a variety of partnering arrangements, we help you keep these assets advancing on schedule - an absolute necessity to maximize the value of your product portfolio and your company.

    We do this through a powerful combination of strategic and financial resourcing. Through the clinical and commercial teams, we can provide unequalled therapeutic and drug development experience, as well as world-class marketing services and sales force operations, which gives you full access to the global resources and reach of Quintiles.

    How can Quintiles help you?

    The capital group underwrites the cost of Quintiles clinical development services in return for milestone and/or royalty payments as the product begins to generate income. This means that your out-of-pocket costs early in the partnership are relatively low, and payments increase only when they can be funded largely through revenues generated by the product itself. By sharing your investment risk, we can help you maximize the upside of your portfolio and move multiple assets through clinical development both in Japan and abroad.

    What are Quintiles prime targets?

    Since partnerships are based on a principle of income and risk sharing, we primarily target:

    • Late-stage development projects (Phase IIb and on)
    • Products already approved outside Japan
    • Line extensions
    • New formulations

    Quintiles partnership and capital business models are tailored to meet each client's individual needs, please contact us today to discover what we can do for you.